Concurrent Investment Advisors LLC purchased a new stake in shares of Relx Plc (NYSE:RELX - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,877 shares of the technology company's stock, valued at approximately $498,000.
Several other institutional investors have also modified their holdings of RELX. Cambridge Investment Research Advisors Inc. increased its holdings in Relx by 19.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,957 shares of the technology company's stock worth $956,000 after purchasing an additional 3,092 shares during the period. Merit Financial Group LLC increased its holdings in Relx by 77.7% during the 1st quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company's stock worth $593,000 after purchasing an additional 5,139 shares during the period. Public Employees Retirement System of Ohio increased its holdings in Relx by 21.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 162,830 shares of the technology company's stock worth $7,396,000 after purchasing an additional 28,702 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Relx by 19.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company's stock worth $6,517,000 after purchasing an additional 23,183 shares during the period. Finally, Money Concepts Capital Corp increased its holdings in Relx by 237.4% during the 1st quarter. Money Concepts Capital Corp now owns 15,604 shares of the technology company's stock worth $787,000 after purchasing an additional 10,979 shares during the period. 15.02% of the stock is owned by institutional investors.
Relx Stock Up 0.5%
NYSE RELX traded up $0.28 during midday trading on Monday, hitting $53.90. 1,091,294 shares of the company traded hands, compared to its average volume of 757,226. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The company has a market cap of $98.99 billion, a PE ratio of 28.98, a price-to-earnings-growth ratio of 3.23 and a beta of 0.83. The company's 50-day simple moving average is $53.77 and its 200-day simple moving average is $50.89. Relx Plc has a 52 week low of $43.45 and a 52 week high of $56.33.
Analyst Ratings Changes
RELX has been the topic of several research reports. Wall Street Zen downgraded Relx from a "buy" rating to a "hold" rating in a report on Saturday. The Goldman Sachs Group assumed coverage on Relx in a report on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Buy".
Read Our Latest Research Report on Relx
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.